Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

UN: Spread of MERS in South Korea Isn't Global Emergency

June 17, 2015 8:42 am | by Maria Cheng, AP Medical Writer | News | Comments

WHO acknowledged there were still fundamental gaps in its understanding of the disease nearly three years after MERS was first identified. Read more...


Oramed Granted Patent in Russia for Oral Administration of GLP-1

June 17, 2015 8:38 am | News | Comments

GLP-1 is an incretin hormone that stimulates the secretion of insulin from the pancreas. Read more...


Antibiotics Not Given Same Research Attention as Rare Diseases, Says Report

June 16, 2015 1:12 pm | by Stephanie Guzowski, Editor | News | Comments

In a report that highlights the striking difference between research into rare diseases, vaccines and antibiotics across the globe, there exists a major concern: the antibiotics market is at “risk of losing another decade to inadequate levels of research and innovations,” according to a new report, released today at the BIO International Convention 2015 in Philadelphia. Read more...


Breakthrough Points to Cure for Debilitating Heart and Lung Disease

June 16, 2015 11:01 am | by University of Lincoln | News | Comments

A protein that targets the effects of a faulty gene could offer the first treatment targeting the major genetic cause of Pulmonary Arterial Hypertension (PAH), according to research funded by the British Heart Foundation (BHF). Read more....


Avalon Ventures, GSK Launch Three New Companies

June 16, 2015 10:54 am | News | Comments

Avalon Ventures today announced the launch of three new companies formed through its ongoing successful collaboration with GSK to fund and launch up to 10 early-stage life science companies. Read more..


Pneumonia Found to Harm DNA in Lung Cells

June 16, 2015 10:50 am | by Jessica Fujimori, MIT News correspondent | News | Comments

A bacterium that is the most common cause of pneumonia — a leading cause of death worldwide — can damage DNA in lung cells, a new study has shown. Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) demonstrated that hydrogen peroxide secreted by some strains of Streptococcus pneumoniae causes DNA in human lung cells to suffer double-strand breaks. Read more...


Scripps Florida Study Points to Drug Target for Huntington’s Disease

June 16, 2015 10:44 am | by The Scripps Research Institute | News | Comments

Huntington’s disease attacks the part of the brain that controls movement, destroying nerves with a barrage of toxicity, yet leaves other parts relatively unscathed. Read more...


Vital Genes in Fat Production Found

June 16, 2015 10:40 am | by Hannah Robbins, Harvard Correspondent | News | Comments

Harvard Stem Cell Institute (HSCI) scientists have found a way to both make more energy-burning human brown fat cells and make the cells themselves more active, a discovery that could have therapeutic potential for diabetes, obesity, and other metabolic diseases. Read more...


How Genomics is Being Used to Diagnose, Treat Cancer

June 16, 2015 8:51 am | by Ryan Bushey, Associate Editor | Videos | Comments

The American Association for Cancer Research (AACR) is currently hosting its annual conference on precision medicine in Salt Lake City, Utah. Read more...


MERS Not Given Same Vaccine Attention as Ebola, Other Viruses

June 16, 2015 8:50 am | by Seth Augenstein, Digital Reporter | Articles | Comments

Authorities are scrambling to control the spread of the illness, known fully as the Middle East Respiratory Syndrome. Read more...


Avocados May Hold the Answer to Beating Leukemia

June 15, 2015 4:18 pm | by University of Waterloo | News | Comments

New research reveals that molecules derived from avocados could be effective in treating a form of cancer. Read more...


Behavior Matters: Redesigning the Clinical Trial

June 15, 2015 3:59 pm | by California Institute of Technology | News | Comments

When a new type of drug or therapy is discovered, double-blind randomized controlled trials (DBRCTs) are the gold standard for evaluating them. These trials, which have been used for years, were designed to determine the true efficacy of a treatment free from patient or doctor bias, but they do not factor in the effects that patient behaviors, such as diet and lifestyle choices, can have on the tested treatment. Read more...


Novartis Presents New Data from Large European Study of Tasigna

June 15, 2015 3:37 pm | News | Comments

The final results of this large study, conducted in 26 European countries, were presented at the 20th Congress of the European Hematology Association (EHA) in Vienna. Read more...


Actavis Begins Operating as Allergan

June 15, 2015 3:10 pm | News | Comments

Allergan has initiated a rebranding campaign that will guide the transition of its facilities, operations and commercial presence around the world to the new company name. Read more...


Battling Brain Tumors

June 15, 2015 2:54 pm | by Washington University in St. Louis | News | Comments

The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.